AFP and neoplasm: Although time on the waiting list and AFP level before LTx did not significantly affect survival, tumour progression was significantly associated with worse DFS (HR 1.50, 95 per cent c.i. 1.03 to 2.20; P = 0.035) and OS (HR 1.80,1.20 to 2.71; P = 0.005) (Table 2).